KIRREL1
Kin of IRRE-like protein 1
Also known as: KIRR1_HUMAN, KIRREL, NEPH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96J84
- Gene
- KIRREL1
- Ensembl
- ENSG00000183853
- Chromosome
- 1
- Canonical length
- 757 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
NEPH1 is a member of the nephrin-like protein family, which includes NEPH2 (MIM 607761) and NEPH3 (MIM 607762). The cytoplasmic domains of these proteins interact with the C terminus of podocin (NPHS2; MIM 604766), and the genes are expressed in kidney podocytes, cells involved in ensuring size- and charge-selective ultrafiltration (Sellin et al., 2003 [PubMed 12424224]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
757 residues, UniProt reviewed canonical sequence.
>Q96J84|KIRREL1
1 MLSLLVWILT LSDTFSQGTQ TRFSQEPADQ TVVAGQRAVL PCVLLNYSGI VQWTKDGLAL
61 GMGQGLKAWP RYRVVGSADA GQYNLEITDA ELSDDASYEC QATEAALRSR RAKLTVLIPP
121 EDTRIDGGPV ILLQAGTPHN LTCRAFNAKP AATIIWFRDG TQQEGAVAST ELLKDGKRET
181 TVSQLLINPT DLDIGRVFTC RSMNEAIPSG KETSIELDVH HPPTVTLSIE PQTVQEGERV
241 VFTCQATANP EILGYRWAKG GFLIEDAHES RYETNVDYSF FTEPVSCEVH NKVGSTNVST
301 LVNVHFAPRI VVDPKPTTTD IGSDVTLTCV WVGNPPLTLT WTKKDSNMVL SNSNQLLLKS
361 VTQADAGTYT CRAIVPRIGV AEREVPLYVN GPPIISSEAV QYAVRGDGGK VECFIGSTPP
421 PDRIAWAWKE NFLEVGTLER YTVERTNSGS GVLSTLTINN VMEADFQTHY NCTAWNSFGP
481 GTAIIQLEER EVLPVGIIAG ATIGASILLI FFFIALVFFL YRRRKGSRKD VTLRKLDIKV
541 ETVNREPLTM HSDREDDTAS VSTATRVMKA IYSSFKDDVD LKQDLRCDTI DTREEYEMKD
601 PTNGYYNVRA HEDRPSSRAV LYADYRAPGP ARFDGRPSSR LSHSSGYAQL NTYSRGPASD
661 YGPEPTPPGP AAPAGTDTTS QLSYENYEKF NSHPFPGAAG YPTYRLGYPQ APPSGLERTP
721 YEAYDPIGKY ATATRFSYTS QHSDYGQRFQ QRMQTHVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KIRREL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 28 nTPM
- ovary: 26 nTPM
- placenta: 26 nTPM
- smooth muscle: 23 nTPM
- gallbladder: 20 nTPM
- adipose tissue: 20 nTPM
Single-cell type
- podocytes: 775 nCPM
- adrenal cortex cells: 169 nCPM
- pituicytes/fscs: 165 nCPM
- fibro-adipogenic progenitors: 153 nCPM
- vascular smooth muscle cells: 150 nCPM
- pericytes: 147 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 19 nTPM
- midbrain: 9.5 nTPM
- thalamus: 8.7 nTPM
- cerebellum: 8.4 nTPM
- spinal cord: 8.2 nTPM
- amygdala: 7.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KIRREL1.
Disease | AllUniProt
Conditions KIRREL1 is implicated in, by any mechanism.
- Nephrotic syndrome 23 (NPHS23) MIM:619201
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 153 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nephrotic syndrome, type 23
ReferencesPubMed · IEDB
Publications for KIRREL1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications.
2026 · Nephrol Dial Transplant · RCR 8 · 8 citations - Antinephrin, Antipodocin, and Anti-Kirrel1 Autoantibodies in Posttransplant Recurrent FSGS.
2026 · Kidney Int Rep - Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.
2026 · J Am Soc Nephrol
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell adhesion
- cell-cell junction maintenance
- glomerular filtration
- positive regulation of actin filament polymerization
- renal protein absorption
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin I-set
- CD80-like, immunoglobulin C2-set
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Cellular adhesion and signaling domain-containing protein
- Immunoglobulin I-set domain
- CD80-like C2-set immunoglobulin domain
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KIRREL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KIRREL1 as an antibody target. Whether an autoantibody or antibody against KIRREL1 could matter depends on whether native KIRREL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KIRREL1 is annotated at the cell surface, where native KIRREL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KIRREL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...